Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022Research in context

• Auteurs principaux: Ryan E. Wiegand (Auteur), Yangyang Deng (Auteur), Xiaoyi Deng (Auteur), Adam Lee (Auteur), William A. Meyer, III (Auteur), Stanley Letovsky (Auteur), Myrna D. Charles (Auteur), Adi V. Gundlapalli (Auteur), Adam MacNeil (Auteur), Aron J. Hall (Auteur), Natalie J. Thornburg (Auteur), Jefferson Jones (Auteur), Ronaldo Iachan (Auteur), Kristie E.N. Clarke (Auteur)
• Format: Livre
• Publié: Elsevier, 2023-02-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Summary: Background: Sero-surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can reveal trends and differences in subgroups and capture undetected or unreported infections that are not included in case-based surveillance systems. Methods: Cross-sectional, convenience sample...